{"id":956251,"date":"2026-04-29T17:00:42","date_gmt":"2026-04-29T21:00:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/"},"modified":"2026-04-29T17:00:42","modified_gmt":"2026-04-29T21:00:42","slug":"the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/","title":{"rendered":"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><strong>The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN<\/strong><\/p>\n<p class=\"bwalignc\"><i>Surgeon-Founded Brand Anchored by Innovative NAC Y2\u2122 Technology<\/i><\/p>\n<p>NEW YORK&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nThe Est\u00e9e Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20260429495879\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260429495879\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260429495879\/en\/2789643\/4\/REP_Collection_2024_RGB.jpg\" alt=\"111SKIN's Reparative Collection\" \/><\/p>\n<p style=\"font-size:85%\">111SKIN&#8217;s Reparative Collection<\/p>\n<\/div>\n<p>\nFounded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients\u2019 healing time following procedures. At the heart of the brand is its innovative NAC Y2\u2122, a pioneering complex designed to support skin repair and maintain a healthy, radiant and resilient complexion. Building on the foundation of this clinical expertise, 111SKIN has developed a portfolio of more than 30 products, anchored by its Black Diamond and Reparative collections and priced from $50 to $1,000.<\/p>\n<p>\n\u201cSkin care is entering a new phase, shaped by the convergence of procedures, longevity and beauty, as consumers increasingly seek products that deliver visible, treatment-inspired results,\u201d said St\u00e9phane de La Faverie, President and Chief Executive Officer, The Est\u00e9e Lauder Companies. \u201c111SKIN exemplifies this shift, translating Dr. Alexandrides\u2019 more than 35 years of surgical and aesthetic treatment experience into high-performance luxury skin care inspired by in-clinic treatments and built on clinical insight, next-generation actives, powerful formulas and proven efficacy. This investment, grounded in consumer-centricity and transformative innovation, reflects our Beauty Reimagined vision and underscores the significant opportunity we see to support the brand\u2019s continued growth \u2013 expanding its global reach while preserving the distinctive approach that has made it so relevant with today\u2019s consumers.\u201d<\/p>\n<p>\n111SKIN is a luxury clinical skin care brand, operating in a fast-growing segment where medical expertise and powerful high-performance formulations are increasingly shaping consumer demand. The brand distributes through luxury retail, e-commerce and high-end spa channels \u2013 including Harrods, Bluemercury, Nordstrom, Mandarin Oriental, and Aman \u2013 and has a robust direct-to-consumer business representing approximately 20% of sales, reflecting strong digital engagement with prestige consumers. The brand has a diversified global footprint, with North America representing approximately 40% of 2025 sales, and an established presence across China, the United Kingdom, Europe and Asia Pacific.<\/p>\n<p>\n\u201cWe are thrilled to be partnering with The Est\u00e9e Lauder Companies and to unlock an exciting new chapter for 111SKIN,\u201d said Dr. Yannis and Eva Alexandrides, co-founders of 111SKIN. \u201cWe look forward to building on our momentum and driving future growth together,\u201d added CEO Vanessa Goddevrind.<\/p>\n<p>\nDr. Alexandrides will remain actively involved in the brand and will continue to lead 111SKIN alongside its experienced management team.<\/p>\n<p>\nThis investment aligns with The Est\u00e9e Lauder Companies\u2019 continued focus on science-driven innovation, as 111SKIN\u2019s advanced NAC Y2\u2122 technology and commitment to clinical-led product development reflect consumers\u2019 growing preference for high-performance and preventative skin care.<\/p>\n<p><b><span class=\"bwuline\">About The Est\u00e9e Lauder Companies Inc.<br \/>\n<br \/><\/span><\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.elcompanies.com%2Fen&amp;esheet=54525546&amp;newsitemid=20260429495879&amp;lan=en-US&amp;anchor=The+Est%26eacute%3Be+Lauder+Companies+Inc.&amp;index=1&amp;md5=08c53de97dc92a5bf18e76304e76137f\">The Est\u00e9e Lauder Companies Inc.<\/a> is one of the world\u2019s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company\u2019s products are sold in approximately 150 countries and territories under brand names including: Est\u00e9e Lauder, Aramis, Clinique, Lab Series, Origins, M\u00b7A\u00b7C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Fr\u00e9d\u00e9ric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.<\/p>\n<p>\nELC-C<br \/>\n<br \/>ELC-B<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260429495879r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260429495879\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260429495879\/en\/<\/a><\/span><\/p>\n<p><b>Investor Relations:<br \/>\n<\/b><br \/><b>Rainey Mancini<br \/>\n<\/b><br \/><a rel=\"nofollow\" href=\"mailto:rmancini@estee.com\">rmancini@estee.com<\/a><\/p>\n<p><b>Media Relations:<br \/>\n<\/b><br \/><b>Brendan Riley<br \/>\n<\/b><br \/><a rel=\"nofollow\" href=\"mailto:briley@estee.com\">briley@estee.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> New York United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Cosmetics Retail Luxury Health Surgery Other Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260429495879\/en\/2789643\/3\/REP_Collection_2024_RGB.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">111SKIN&#8217;s Reparative Collection<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260429495879\/en\/399480\/3\/elcompanieslogo655.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN Surgeon-Founded Brand Anchored by Innovative NAC Y2\u2122 Technology NEW YORK&#8211;(BUSINESS WIRE)&#8211; The Est\u00e9e Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260429495879\/en\/ 111SKIN&#8217;s Reparative Collection Founded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients\u2019 healing time following procedures. At the heart of the brand is its innovative NAC Y2\u2122, a pioneering complex designed to support skin repair and maintain a healthy, radiant and resilient complexion. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-956251","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN Surgeon-Founded Brand Anchored by Innovative NAC Y2\u2122 Technology NEW YORK&#8211;(BUSINESS WIRE)&#8211; The Est\u00e9e Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260429495879\/en\/ 111SKIN&#8217;s Reparative Collection Founded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients\u2019 healing time following procedures. At the heart of the brand is its innovative NAC Y2\u2122, a pioneering complex designed to support skin repair and maintain a healthy, radiant and resilient complexion. &hellip; Continue reading &quot;The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-29T21:00:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260429495879\/en\/2789643\/4\/REP_Collection_2024_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN\",\"datePublished\":\"2026-04-29T21:00:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/\"},\"wordCount\":660,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260429495879\\\/en\\\/2789643\\\/4\\\/REP_Collection_2024_RGB.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/\",\"name\":\"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260429495879\\\/en\\\/2789643\\\/4\\\/REP_Collection_2024_RGB.jpg\",\"datePublished\":\"2026-04-29T21:00:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260429495879\\\/en\\\/2789643\\\/4\\\/REP_Collection_2024_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260429495879\\\/en\\\/2789643\\\/4\\\/REP_Collection_2024_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/","og_locale":"en_US","og_type":"article","og_title":"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN - Market Newsdesk","og_description":"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN Surgeon-Founded Brand Anchored by Innovative NAC Y2\u2122 Technology NEW YORK&#8211;(BUSINESS WIRE)&#8211; The Est\u00e9e Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260429495879\/en\/ 111SKIN&#8217;s Reparative Collection Founded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients\u2019 healing time following procedures. At the heart of the brand is its innovative NAC Y2\u2122, a pioneering complex designed to support skin repair and maintain a healthy, radiant and resilient complexion. &hellip; Continue reading \"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-29T21:00:42+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260429495879\/en\/2789643\/4\/REP_Collection_2024_RGB.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN","datePublished":"2026-04-29T21:00:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/"},"wordCount":660,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260429495879\/en\/2789643\/4\/REP_Collection_2024_RGB.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/","name":"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260429495879\/en\/2789643\/4\/REP_Collection_2024_RGB.jpg","datePublished":"2026-04-29T21:00:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260429495879\/en\/2789643\/4\/REP_Collection_2024_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260429495879\/en\/2789643\/4\/REP_Collection_2024_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/the-estee-lauder-companies-announces-minority-investment-in-luxury-clinical-skin-care-brand-111skin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"The Est\u00e9e Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/956251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=956251"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/956251\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=956251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=956251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=956251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}